Celeste Rachelle Fralick serves as Executive at Aspira Women's Health Inc., where they oversee executive responsibilities. Since joining the company, Celeste Rachelle Fralick has executed 7 insider transactions totaling $3.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 12, 2024 involved receiving (via award) 15,381 shares valued at $0.
Celeste Rachelle Fralick currently holds 40,665 shares of Aspira Women's Health Inc. (AWH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Celeste Rachelle Fralick has been a net buyer of AWH stock. They have purchased $3.0K and sold $0 worth of shares.
Celeste Rachelle Fralick's most recent insider trade was on Aug 12, 2024, when they sold 15,381 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 25, 2023 | AWH | $0 | Award | 13,252 | $N/A | Discretionary |
| Jul 24, 2023 | AWH | $3.0K | Purchase | 754 | $3.98 | Discretionary |
| Feb 9, 2023 | AWH | $0 | Award | 66,254 | $N/A | Discretionary |
| Aug 25, 2022 | AWH | $0 | Purchase | 6,667 | $N/A | Discretionary |
| Mar 31, 2022 | AWH | $0 | Award | 99,671 | $N/A | Discretionary |